Natco Pharma

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue431.60798.701,063955.20654.80
Expenses386.60492.30587.70531.20431.20
EBITDA86.10345.20518.30467.00267.80
EBIT48.00307.60478.40427.00227.40
Profit Before Tax45.00306.40475.20424.00223.60
Net Profit37.30254.10405.30360.20192.00
Financial Ratios
Operating Profit Margin20.85%44.19%49.44%50.19%42.83%
Net Profit Margin9.03%32.53%38.66%38.71%30.71%
Earning Per Share (Diluted)2.0413.9222.4320.1110.72
Dividends Per Share1.250.007.000.001.25
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ